Oral Cancer Clinical Trial
Official title:
Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis
The purpose of this study is to determine the effects of a novel oral care protocol on the severity and pain of oral mucositis in patients receiving radiation and/or chemotherapy for head and neck cancers. The secondary objectives are to characterize the microbiome associated with oral mucositis, measure salivary proinflammatory cytokines, and evaluate other clinical indicators of the intervention. Participants will be enrolled prior to beginning radiation and/or chemotherapy, and will be randomized to receive either the oral health protocol or standard of care oral hygiene.
Oral mucositis (OM) is one of the most debilitating adverse effects in cancer patients
treated with chemotherapy or radiation (RT). Currently, there are no effective therapies or
prevention for mucositis, while several clinical studies have suggested that professional
oral care could effectively reduce the severity of Radiation Therapy or chemotherapy-induced
oral mucositis. Palliative treatment, rather than preventive or curative measures, remains
the standard of care. Evidence-based guidelines do not provide consistent recommendations for
the prevention, treatment and management of oral mucositis.
The investigators hypothesize that a monitored regimen of professional oral hygiene prevents
harmful ecological shifts in the oral cavity, improve oral health and reduce the duration and
severity of Oral Mucositis in cancer patients, consequently improving their overall quality
of life during treatment. Moreover, the investigators hypothesize that the weekly oral
hygiene regimen performed by an oral health professional is more effective in treating and
preventing mucositis than current standard-of-care treatments.
The principal investigator of this project has developed a novel oral care regimen protocol
for the treatment of oral mucositis. The "Oral Mucosa Deterging and Periodontal Debridement"
(OMDP) protocol consists of a regimen of frequent professional oral prophylaxis including
tooth cleaning, tooth polishing and flossing, and the debridement of the periodontium and
deterging of the oral mucosa. This is an intervention that is implemented prior to and
maintained throughout the entire cycle of the radiation or chemoradiation. Co-adjuvant
treatments such as intense fluoride treatments, oral hygiene instructions and palliative
mouth-rinses are also part of the protocol. The hypothesis is that repeated professional
prophylaxis of the oral cavity would protect the healthy oral tissue against infection and
inflammation often associated with severe cases of mucositis, and consequently reduces
mucositis incidence and duration.
Participants in this study would attend approximately 9 study visits over the course of 16-18
weeks, depending on their specific cancer treatment plan. Study participants will be
randomized to receive either the oral health protocol, which they will receive on a weekly
basis, or standard of care oral hygiene instructions and tooth brushing, preformed on a
bi-weekly basis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06031337 -
Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
|
||
Completed |
NCT00158678 -
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
|
Phase 3 | |
Completed |
NCT00933387 -
A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma
|
Phase 2 | |
Enrolling by invitation |
NCT05030597 -
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
|
N/A | |
Completed |
NCT03682562 -
Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
|
||
Recruiting |
NCT03684707 -
Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions
|
Phase 4 | |
Recruiting |
NCT06130332 -
Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)
|
Phase 2 | |
Recruiting |
NCT04372914 -
Prevention of Oral DNA Damage by Black Raspberries
|
N/A | |
Active, not recruiting |
NCT03529422 -
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
|
Phase 2 | |
Recruiting |
NCT03686020 -
Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
|
||
Not yet recruiting |
NCT06060288 -
Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
|
||
Withdrawn |
NCT00951470 -
Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
|
N/A | |
Completed |
NCT00964977 -
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
|
Phase 3 | |
Completed |
NCT01418118 -
Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
|
Phase 4 | |
Active, not recruiting |
NCT00232960 -
Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
|
N/A | |
Recruiting |
NCT05429099 -
Mandibular Reconstruction Preplanning (ViPMR)
|
Phase 2/Phase 3 | |
Completed |
NCT04614896 -
Use of Ultrasound for Measuring Size of Oral Tongue Cancers
|
N/A | |
Recruiting |
NCT03685409 -
Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions
|
Phase 3 | |
Completed |
NCT00402779 -
Erlotinib Prevention of Oral Cancer (EPOC)
|
Phase 3 | |
Recruiting |
NCT05153733 -
Improved Implant for Reconstruction Purposes After Mandibular Resection
|
N/A |